Ім'я файлу: cptclpt201183-sup-0004 (1).doc
Розширення: doc
Розмір: 86кб.
Дата: 02.12.2021
скачати
Пов'язані файли:
ID_4876_аналіз біосигналів- обробка ме_українська_sem_4-rtf.rtf
методичка історія хвороби 2021.pdf
New Microsoft Word Document (2).docx
docsity-istoriya-hvorobi-virazka-shlunka-1.pdf
07. Клапті з осьовим судинним малюнком_acf57c02d31a810135e6e0799


Table S1. Demographic and Clinical Characteristics of Cohorts of Patients on SSRIs and statins

SSRI

SA or FL

PA

PA, SA, or FL

PA

SA

FL

Statin

AT, SI, RO, or LO

AT, SI, RO, or LO

PR

PR

AT

SI

RO

LO

PR

AT

SI

RO

PR

AT

SI

RO

LO

N

324

115

38

8

49

53

7

10

12

76

61

14

18

49

45

13

12

Demographics




















































Age

(mean ± SD)

66.9

± 13.6

67.9

± 13.5

61.2

± 16.4

63.1

± 10.1

68.0

± 13.7

69.8

± 14.6 †

60.9

± 17.2

68.0

± 8.9

57.8

± 15.9

71.4

± 12.7 †

69.1

± 13.9 †

56.9

± 10.1

62.7

± 18.6

68.1

± 12.2

66.5

± 14.1

65.6

± 7.0

60.9

± 12.4

Gender (% Female)

57 †

56†

55

88

55

55

57

60

67

57

51 †

57

33 †

63

64

62

75

Race (% of group)




















































    • White

65

62

71

63

67

60

71

40

83

63

64

71

67

65

62

69

25

    • African American

3

3

5

0

4

4

0

0

0

8

3

0

11

2

0

0

8

    • Hispanic

7

0

0

8

2

4

14

0

0

13

5

7

0

4

9

8

17

    • Other

25

36

24

30

27

32

14

60

17

16

28

21

22

29

29

23

50

Glucose (mg/dl ± 95% CI)











































Baseline (base)

126.5

± 4.2 †

123.3

± 6.8

113.5

± 8.7

112.6

± 11.1

128.5

± 12.2

126.2

± 8.5

103.3

± 13.1

117.6

± 21.3

118.5 

± 20.7

121.3

± 6.9

125.5

± 9.8

117.7

± 14.8

110.5

± 11.0

114.8

± 6.3

122.7

± 9.7

116.1

± 10.9

128.4

± 19.0

    • mmol/L

7.0

± 0.2

6.8

± 0.4

6.3

± 0.5

6.2

± 0.6

7.1

± 0.7

7.0

± 0.5

5.7

± 0.7

6.5

± 1.2

6.6

± 1.1

6.7

± 0.4

7.0

± 0.5

6.5

± 0.8

6.1

± 0.6

6.4

± 0.3

6.8

± 0.5

6.4

± 0.6

7.1

± 1.1

After treatment(s) (post)

128.2

± 3.4

127.6

± 6.6

123.0

± 8.6

135.2

± 13.8

136.9

± 12.8

125.5

± 6.8

106.4

± 6.5 †

123.3

± 16.9

125.9

± 18.6

122.1

± 6.4

119.0

± 5.9

129.9

± 10.9

115.6

± 10.8 †

121.4

± 5.9

129.7

± 9.8

117.1

± 12.0

130.1

± 16.9

    • mmol/L

7.1

± 0.2

7.1

± 0.4

6.8

± 0.5

7.5

± 0.8

7.6

± 0.7

7.0

± 0.4

5.9

± 0.4

6.8

± 0.9

7.0

± 1.0

6.8

± 0.4

6.6

± 0.3

7.2

± 0.6

6.4

± 0.6

6.7

± 0.3

7.1

± 0.5

6.5

± 0.7

7.2

± 0.9

Change (base to post)

1.7

± 3.0 †

4.2

± 5.5

9.5

± 6.4

22.6

± 16.5

8.4

± 10.1

-0.7

± 6.8 †

3.1

± 9.3

5.7

± 11.1

7.4

± 9.3

0.8

± 5.6 †

-6.5

± 7.1 †

12.2

± 11.3

5.1

± 8.8

6.6

± 4.8

7.0

± 7.0

1.0

± 12.2

1.6

± 9.4 †

    • mmol/L

0.1

± 0.2

0.2

± 0.3

0.5

± 0.4

1.3

± 0.9

0.5

± 0.6

0.0

± 0.4

0.2

± 0.5

0.3

± 0.6

0.4

± 0.5

0.0

± 0.3

-0.4

± 0.4

0.7

± 0.6

0.3

± 0.5

0.4

± 0.3

0.4

± 0.4

0.1

± 0.7

0.1

± 0.5

paired t-test (t: post - base)

0.02

0.05

0.008

0.04

0.06

0.86

0.42

0.29

0.13

0.66

0.19

0.04

0.30

0.008

0.05

0.90

0.64

N pat incr glu

164 (51)

57 (50)

20 (53)

6 (75)

26 (54)

24 (45)

5 (71)

4 (40)

6 (50)

34 (47)

25 (41) †

10 (71)

8 (44)

33 (67)

30 (67)

4 (31) †

5 (42)

Power to detect 20mg/dl

1.00

1.0

1.0

0.52

0.78

0.98

0.78

0.65

0.84

1.0

0.97

0.64

0.87

1.0

0.97

0.60

0.79



    • SE = Sertraline, FL = fluoxetine, PA = paroxetine, AT = atorvastatin, SI = simvastatin, RO = rosuvastatin, LO = lovastatin, PR = pravastatin.

    • † Identifies values which are significantly (p ≤ 0.05) different when compared to the corresponding values under PR and PA Combination therapy.



скачати

© Усі права захищені
написати до нас